Torthaí cuardaigh - Issa, Samar

Carbazole scaffolds in cancer therapy: a review from 2012 to 2018 de réir Issa, Samar, Prandina, Anthony, Bedel, Nicolas, Rongved, Pål, Yous, Saïd, Le Borgne, Marc, Bouaziz, Zouhair

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Regulation of microRNAs in Cancer Metastasis de réir Bouyssou, Juliette M.C., Manier, Salomon, Huynh, Daisy, Issa, Samar, Roccaro, Aldo M., Ghobrial, Irene M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma de réir van der Meulen, Matthijs, Dirven, Linda, Bakunina, Katerina, van den Bent, Martin J., Issa, Samar, Doorduijn, Jeanette K., Bromberg, Jacoline E. C.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

NCOG-05. IMPACT OF ADDITIONAL RITUXIMAB TO STANDARD THERAPY ON COGNITIVE PERFORMANCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS de réir van der Meulen, Matthijs, Dirven, Linda, Habets, Esther, Bakunina, Katerina, Taphoorn, Martin, van den Bent, Martin, Issa, Samar, Doorduijn, Jeanette K, Bromberg, Jacoline E C

Faigh an téacs iomlán Faigh an téacs iomlán

Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation – an International Primary Central Nervous System Lymphoma Study Group project de réir Bromberg, Jacoline E., Doorduijn, Jeanette K., Illerhaus, Gerald, Jahnke, Kristoph, Korfel, Agniezka, Fischer, Lars, Fritsch, Kristina, Kuittinen, Outti, Issa, Samar, van Montfort, Cees, van den Bent, Martin J.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

CLRM-15 TRIAL IN PROGRESS: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT INHIBITOR OF BRUTON’S TYROSINE KINASE (BTKI) FOR RELAPSED/REFRACTORY P... de réir Soussain, Carole, Grommes, Christian, Issa, Samar, Ward, Renee, Peterson, Caryn, Cravets, Matt, Mathias, Anita, Sosa, Judith, Kirby, Brian, Ding, Zhaoqing, Yusuf, Isharat, Rose, Mark, Steinberg, Marcos, Tun, Han W

Faigh an téacs iomlán Faigh an téacs iomlán

Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI de réir Wieduwilt, Matthew J., Valles, Francisco, Issa, Samar, Behler, Caroline M., Hwang, James, McDermott, Michael, Treseler, Patrick, O’Brien, Joan, Shuman, Marc A., Cha, Soonmee, Damon, Lloyd E., Rubenstein, James L.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Fo... de réir Flinn, Ian W., van der Jagt, Richard, Kahl, Brad, Wood, Peter, Hawkins, Tim, MacDonald, David, Simpson, David, Kolibaba, Kathryn, Issa, Samar, Chang, Julie, Trotman, Judith, Hallman, Doreen, Chen, Ling, Burke, John M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study de réir Flinn, Ian W., van der Jagt, Richard, Kahl, Brad S., Wood, Peter, Hawkins, Tim E., MacDonald, David, Hertzberg, Mark, Kwan, Yiu-Lam, Simpson, David, Craig, Michael, Kolibaba, Kathryn, Issa, Samar, Clementi, Regina, Hallman, Doreen M., Munteanu, Mihaela, Chen, Ling, Burke, John M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Extent of radiological response does not reflect survival in primary central nervous system lymphoma de réir van der Meulen, Matthijs, Postma, Alida A, Smits, Marion, Bakunina, Katerina, Minnema, Monique C, Seute, Tatjana, Cull, Gavin, Enting, Roelien H, van der Poel, Marjolein, Stevens, Wendy B C, Brandsma, Dieta, Beeker, Aart, Doorduijn, Jeanette K, Issa, Samar, van den Bent, Martin J, Bromberg, Jacoline E C

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial de réir van der Meulen, Matthijs, Dirven, Linda, Habets, Esther J J, Bakunina, Katerina, Smits, Marion, Achterberg, Hakim C, Seute, Tatjana, Cull, Gavin, Schouten, Harry, Zijlstra, Josée M, Brandsma, Dieta, Enting, Roelien H, Beijert, Max, Taphoorn, Martin J B, van den Bent, Martin J, Issa, Samar, Doorduijn, Jeanette K, Bromberg, Jacoline E C

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets de réir Yeung, David T., Osborn, Michael P., White, Deborah L., Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark, Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Trotman, Judith, Forsyth, Cecily J., Taper, John, Ross, David M., Beresford, Jennifer, Tam, Constantine, Mills, Anthony K., Grigg, Andrew P., Hughes, Timothy P.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán